Angiogenesis in arthritis: role in disease pathogenesis and as a potential therapeutic target Ewa M. PaleologJadwiga M. Miotla OriginalPaper Pages: 295 - 307
Placental angiogenesis: the role of the VEGF family of proteins Dawn E. ClarkD. Stephen Charnock-Jones OriginalPaper Pages: 309 - 318
A new synthetic matrix metalloproteinase inhibitor modulates both angiogenesis and urokinase type plasminogen activator activity Tadahisa ShonoMasaaki MotoyamaMayumi Ono OriginalPaper Pages: 319 - 329
The formation of tubular structures by endothelial cells is under the control of fibrinolysis and mechanical factors Bruno VailhéMarc LecomteLéone Tranqui OriginalPaper Pages: 331 - 344
Tubular morphogenesis by genotoxic therapeutic agents that induce NF-κB activation in humanvascular endothelial cells Daisuke GotoHiroto IzumiMichihiko Kuwano OriginalPaper Pages: 345 - 356
Identification and characterisation of chicken cDNAs encoding the endothelial cell-specific receptor tyrosine kinase Tie2 and its ligands, the angiopoietins Pamela F. JonesJoyce McClainGeorge D. Yancopoulos OriginalPaper Pages: 357 - 364
Evaluation of tissue and serum VEGF in patients with head and neck carcinoma Christina LinderStig LinderHans Strander OriginalPaper Pages: 365 - 372
Inhibition of angiogenesis in liver metastases by carboxyamidotriazole (CAI) Keith J. LuzziHemanth J. VargheseAlan C. Groom OriginalPaper Pages: 373 - 379